ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,320,000 | +69.9% | 812,247 | +6.0% | 0.03% | +78.9% |
| Q2 2019 | $9,015,000 | +2691.0% | 765,917 | +3135.4% | 0.02% | +1800.0% |
| Q1 2019 | $323,000 | +26.7% | 23,673 | -5.0% | 0.00% | 0.0% |
| Q4 2018 | $255,000 | -38.6% | 24,907 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $415,000 | +1.2% | 24,907 | -4.0% | 0.00% | 0.0% |
| Q2 2018 | $410,000 | +13.6% | 25,956 | -8.6% | 0.00% | 0.0% |
| Q1 2018 | $361,000 | +11.1% | 28,389 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $325,000 | -6.6% | 28,389 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $348,000 | +36.5% | 28,389 | +27.3% | 0.00% | 0.0% |
| Q2 2017 | $255,000 | -40.4% | 22,304 | +8.4% | 0.00% | 0.0% |
| Q1 2017 | $428,000 | 0.0% | 20,570 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $428,000 | -36.5% | 20,570 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $674,000 | +31.1% | 20,570 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $514,000 | +100.0% | 20,570 | +95.9% | 0.00% | 0.0% |
| Q1 2016 | $257,000 | -25.9% | 10,499 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $347,000 | +0.9% | 10,499 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $344,000 | -38.1% | 10,499 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $556,000 | – | 10,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |